AAS
RDY icon

Avantax Advisory Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Avantax Advisory Services’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-112,935
Closed -$1.78M – 2312
2024
Q4 		$1.78M Sell
112,935
-775
-0.7% -$11.6K 0.01% 761
2024
Q3 		$1.81M Buy
113,710
+320
+0.3% +$5.15K 0.01% 753
2024
Q2 		$1.73M Buy
+113,390
New +$1.63M 0.01% 719

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Avantax Advisory Services's RDY Position: Q1 2025 in Review

Avantax Advisory Services sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 112,935 shares — an estimated $1.78M sold.

Avantax Advisory Services first reported a position in RDY in Q2 2024 and held it in 3 quarters. The position peaked at $1.81M in Q3 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Avantax Advisory Services reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Avantax Advisory Services sold 112,935 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $1.78M.
  • Avantax Advisory Services first reported a position in Dr. Reddy's Laboratories in Q2 2024 and held it in 3 quarters.
  • Avantax Advisory Services's Dr. Reddy's Laboratories position peaked at $1.81M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Avantax Advisory Services's 13F filing for Q1 2025, filed 6 May 2025.